Variable | Person-years | Incidence rate/1000 person-years | Mantel-Haenszel estimates of rate ratio | Percent relative effect (%) | Pepe Mori cumulative incidence comparison | |||
---|---|---|---|---|---|---|---|---|
RR | X2 | p value | X2 | p value | ||||
Neoplasia onset after ACS (n = 99) | 5544 |  |  |  |  |  |  |  |
Total cholesterol | ||||||||
 ≤ Median | 23 | 0.54 | 8.8 | 0.003 | 85 | 7.4 | 0.006 | |
 > Median | 13 | |||||||
LDL cholesterol | ||||||||
 ≤ Median | 23 | 0.58 | 7.1 | 0.007 | 72 | 4.6 | 0.03 | |
 > Median | 13 | |||||||
HDL cholesterol | ||||||||
 ≤ Median | 17 | 1.10 | 0.2 | 0.63 | −9 | 0.2 | 0.63 | |
 > Median | 19 | |||||||
Triglycerides | ||||||||
  ≤ median | 20 | 0.75 | 2.0 | 0.16 | 33 | 2.5 | 0.11 | |
  > median | 15 | |||||||
Neoplasia-related death after ACS (n = 75) | 5877 |  |  |  |  |  |  |  |
Total cholesterol | ||||||||
 ≤ Median | 18 | 0.43 | 12.1 | 0.0005 | 133 | 10.7 | 0.001 | |
 > Median | 8 | |||||||
LDL cholesterol | ||||||||
 ≤ Median | 18 | 0.45 | 11.4 | 0.0007 | 122 | 7.8 | 0.005 | |
 > Median | 8 | |||||||
HDL cholesterol | ||||||||
 ≤ Median | 11 | 1.33 | 1.6 | 0.8 | −25 | 0.5 | 0.47 | |
 > Median | 15 | |||||||
Triglycerides | ||||||||
 ≤ Median | 15 | 0.68 | 2.7 | 0.09 | 47 | 1.6 | 0.20 | |
 > Median | 11 |